ISSN: 0032-5481

Journal Home

Journal Guideline

Postgraduate Medicine Q2 Unclaimed

Taylor and Francis Ltd. United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Postgraduate Medicine is a journal indexed in SJR in Medicine (miscellaneous) with an H index of 67. It has a price of 2395 €. It has an SJR impact factor of 0,773 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,773.

Postgraduate Medicine focuses its scope in these topics and keywords: weight, management, july, needed, md, mayo, losspractical, lose, infections, hiv, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Medicine (miscellaneous) (Q2)

Price

2395 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

0,773

SJR Impact factor

67

H Index

108

Total Docs (Last Year)

380

Total Docs (3 years)

5336

Total Refs

1086

Total Cites (3 years)

346

Citable Docs (3 years)

2.5

Cites/Doc (2 years)

49.41

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Clinical Rheumatology Q2
Pharmacological Reports Q2
Journal of Human Nutrition and Dietetics Q2
Diseases of the Colon and Rectum Q2
Oncology Reports Q2

Compare this journals

Aims and Scope

Best articles by citations

Erectile Dysfunction May Improve by Blood Pressure Control in Patients with High-Risk Hypertension

Influence of Asthma Status on Serotype-Specific Pneumococcal Antibody Levels

A Simple Criterion of Obesity

A workable model for the management of hyperglycemia in non-critically ill patients in an Asian population

Osteomyelitis in diabetic foot ulcers

The Medical Bookshelf

SGLT2 inhibitor/DPP-4 inhibitor combination therapy -complementary mechanisms of action for management of type 2 diabetes mellitus

Risk of Upper Gastrointestinal Ulcers in Patients With Osteoarthritis Receiving Single-Tablet Ibuprofen/Famotidine Versus Ibuprofen Alone: Pooled Efficacy and Safety Analyses of Two Randomized, Double-Blind, Comparison Trials

Helping patients who say they cannot sleep

Overcoming qEEG Abnormalities and Reward Gene Deficits during Protracted Abstinence in Male Psychostimulant and Polydrug Abusers Utilizing Putative Dopamine D2Agonist Therapy: Part 2

The New Generation of Liquid Intravenous Immunoglobulin Formulations in Patient Care: A Comparison of Intravenous Immunoglobulins

Treating Obesity in the Family Practice Setting

SHOW MORE ARTICLES

Prevalence and Coexistence of Cardiovascular Comorbidities among the US Dyslipidemic Population Aged = 65 Years by Lipid-Lowering Medication Use Status

Rizatriptan: Comparative trial results

Achieving Weight-loss Maintenance

Treatment of Parkinson's disease

Gonococcal arthritis syndromes

The Role of Alpha2-Adrenergic Agonists in Attention-Deficit/Hyperactivity Disorder

Gas gangrene

rsfMRIeffects of KB220Z‚Ñ¢ on neural pathways in reward circuitry of abstinent genotyped heroin addicts

A U-shaped association between serum uric acid with all-cause mortality in normal-weight population

Efficacy and Safety of Olmesartan Medoxomil in Patients with Stage 1 Hypertension: Blood Pressure Lowering and Goal Achievement

Hypoglycemia in Insulin-Treated Diabetes: A Case for Increased Vigilance

Opioid Therapy for Osteoarthritis and Chronic Low Back Pain